{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:51:06Z","timestamp":1790628666615,"version":"4.1.0"},"reference-count":130,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.4103\/1673-5374.375319","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T08:10:01Z","timestamp":1685002201000},"page":"92-99","source":"Crossref","is-referenced-by-count":41,"title":["The concept of gene therapy for glaucoma"],"prefix":"10.4103","volume":"19","author":[{"given":"Robert","family":"Sulak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Smedowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20230626","doi-asserted-by":"crossref","first-page":"6154","DOI":"10.7150\/thno.55472","article-title":"Inner retinal injury in experimental glaucoma is prevented upon AAV mediated Shp2 silencing in a caveolin dependent manner","volume":"11","author":"Abbasi","year":"(2021)","journal-title":"Theranostics"},{"key":"R2-15-20230626","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/ceo.14035","article-title":"The genetics of glaucoma:disease associations, personalised risk assessment and therapeutic opportunities-A review","volume":"50","author":"Aboobakar","year":"(2022)","journal-title":"Clin Exp Ophthalmol"},{"key":"R3-15-20230626","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.preteyeres.2011.11.002","article-title":"The molecular basis of retinal ganglion cell death in glaucoma","volume":"31","author":"Almasieh","year":"(2012)","journal-title":"Prog Retin Eye Res"},{"key":"R4-15-20230626","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fncel.2020.00090","article-title":"Going the Extra (Synaptic) Mile:excitotoxicity as the road toward neurodegenerative diseases","volume":"14","author":"Armada-Moreira","year":"(2020)","journal-title":"Front Cell Neurosci"},{"key":"R5-15-20230626","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3390\/pharmaceutics14081605","article-title":"Lentiviral vectors for ocular gene therapy","volume":"14","author":"Arsenijevic","year":"(2022)","journal-title":"Pharmaceutics"},{"key":"R6-15-20230626","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/mt.2009.278","article-title":"Prostaglandin pathway gene therapy for sustained reduction of intraocular pressure","volume":"18","author":"Barraza","year":"(2010)","journal-title":"Mol Ther"},{"key":"R7-15-20230626","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.3390\/ijms21072262","article-title":"Neuroprotective strategies for retinal ganglion cell degeneration:current status and challenges ahead","volume":"21","author":"Boia","year":"(2020)","journal-title":"Int J Mol Sci"},{"key":"R8-15-20230626","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3389\/fimmu.2014.00523","article-title":"Evidence that erythropoietin modulates neuroinflammation through differential action on neurons, astrocytes, and microglia","volume":"5","author":"Bond","year":"(2014)","journal-title":"Front Immunol"},{"key":"R9-15-20230626","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.drudis.2019.05.038","article-title":"Ocular gene therapies in clinical practice:viral vectors and nonviral alternatives","volume":"24","author":"Bordet","year":"(2019)","journal-title":"Drug Discov Today"},{"key":"R10-15-20230626","first-page":"80","article-title":"The pathway from genes to gene therapy in glaucoma:a review of possibilities for using genes as glaucoma drugs","volume":"6","author":"Borr\u00e1s","year":"(2017)","journal-title":"Asia Pac J Ophthalmol (Phila"},{"key":"R11-15-20230626","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/gt.2016.14","article-title":"Inducible scAAV2. GRE. MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy","volume":"23","author":"Borr\u00e1s","year":"(2016)","journal-title":"Gene Ther"},{"key":"R12-15-20230626","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/jamaophthalmol.2014.4747","article-title":"Prevention of nocturnal elevation of intraocular pressure by gene transfer of dominant-negative RhoA in rats","volume":"133","author":"Borr\u00e1s","year":"(2015)","journal-title":"JAMA Ophthalmol"},{"key":"R13-15-20230626","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.ymthe.2018.08.017","article-title":"Complement C3-targeted gene therapy restricts onset and progression of neurodegeneration in chronic mouse glaucoma","volume":"26","author":"Bosco","year":"(2018)","journal-title":"Mol Ther"},{"key":"R14-15-20230626","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.gim.2021.10.013","article-title":"The safety and efficacy of gene therapy treatment for monogenic retinal and optic nerve diseases:A systematic review","volume":"24","author":"Britten-Jones","year":"(2022)","journal-title":"Genet Med"},{"key":"R15-15-20230626","doi-asserted-by":"crossref","first-page":"e3559","DOI":"10.21769\/BioProtoc.3559","article-title":"Optic nerve crush in mice to study retinal ganglion cell survival and regeneration","volume":"10","author":"Cameron","year":"(2020)","journal-title":"Bio Protoc"},{"key":"R16-15-20230626","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ophtha.2011.11.003","article-title":"Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement","volume":"119","author":"Chang","year":"(2012)","journal-title":"Ophthalmology"},{"key":"R17-15-20230626","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/s42003-022-04134-w","article-title":"Prostaglandin-based rAAV-mediated glaucoma gene therapy in Brown Norway rats","volume":"5","author":"Chern","year":"(2022)","journal-title":"Commun Biol"},{"key":"R18-15-20230626","doi-asserted-by":"crossref","first-page":"613","DOI":"10.14348\/molcells.2014.0155","article-title":"Oncomodulin\/truncated protamine-mediated Nogo-66 receptor small interference RNA delivery promotes axon regeneration in retinal ganglion cells","volume":"37","author":"Cui","year":"(2014)","journal-title":"Mol Cells"},{"key":"R19-15-20230626","doi-asserted-by":"crossref","first-page":"119","DOI":"10.15283\/ijsc17029","article-title":"Glaucoma, stem cells, and gene therapy:where are we now?","volume":"10","author":"Daliri","year":"(2017)","journal-title":"Int J Stem Cells"},{"key":"R20-15-20230626","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/B978-0-12-407178-0.00007-7","article-title":"Combinatorial therapy stimulates long-distance regeneration, target reinnervation, and partial recovery of vision after optic nerve injury in mice","volume":"106","author":"de Lima","year":"(2012a)","journal-title":"Int Rev Neurobiol"},{"key":"R21-15-20230626","doi-asserted-by":"crossref","first-page":"9149","DOI":"10.1073\/pnas.1119449109","article-title":"Full-length axon regeneration in the adult mouse optic nerve and partial recovery of simple visual behaviors","volume":"109","author":"de Lima","year":"(2012b)","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R22-15-20230626","doi-asserted-by":"crossref","first-page":"e0142067","DOI":"10.1371\/journal.pone.0142067","article-title":"Tackling glaucoma from within the brain:an unfortunate interplay of BDNF and TrkB","volume":"10","author":"Dekeyster","year":"(2015)","journal-title":"PLoS One"},{"key":"R23-15-20230626","doi-asserted-by":"crossref","first-page":"1074099","DOI":"10.3389\/fimmu.2022.1074099","article-title":"Role of metalloproteases in the CD95 signaling pathways","volume":"13","author":"Devel","year":"(2022)","journal-title":"Front Immunol"},{"key":"R24-15-20230626","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.3390\/ijms23073935","article-title":"The role of axonal transport in glaucoma","volume":"23","author":"Dias","year":"(2022)","journal-title":"Int J Mol Sci"},{"key":"R25-15-20230626","doi-asserted-by":"crossref","first-page":"e115579","DOI":"10.1371\/journal.pone.0115579","article-title":"Rescue of retinal function by BDNF in a mouse model of glaucoma","volume":"9","author":"Domenici","year":"(2014)","journal-title":"PLoS One"},{"key":"R26-15-20230626","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41419-021-04068-x","article-title":"BCLX(L) gene therapy moderates neuropathology in the DBA\/2J mouse model of inherited glaucoma","volume":"12","author":"Donahue","year":"(2021)","journal-title":"Cell Death Dis"},{"key":"R27-15-20230626","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4103\/2008-322X.183923","article-title":"Neuroprotection in glaucoma","volume":"11","author":"Doozandeh","year":"(2016)","journal-title":"J Ophthalmic Vis Res"},{"key":"R28-15-20230626","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1016\/S0042-6989(98)00308-3","article-title":"Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV","volume":"39","author":"Dudus","year":"(1999)","journal-title":"Vision Res"},{"key":"R29-15-20230626","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.ymthe.2022.01.035","article-title":"NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function","volume":"30","author":"Fang","year":"(2022)","journal-title":"Mol Ther"},{"key":"R30-15-20230626","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.neuroscience.2009.04.075","article-title":"Combined effect of brain-derived neurotrophic factor and LINGO-1 fusion protein on long-term survival of retinal ganglion cells in chronic glaucoma","volume":"162","author":"Fu","year":"(2009)","journal-title":"Neuroscience"},{"key":"R31-15-20230626","doi-asserted-by":"crossref","first-page":"8374","DOI":"10.1167\/iovs.11-7667","article-title":"Soluble Nogo-66 receptor prevents synaptic dysfunction and rescues retinal ganglion cell loss in chronic glaucoma","volume":"52","author":"Fu","year":"(2011)","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R32-15-20230626","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.omtm.2017.04.003","article-title":"Spatially and temporally regulated NRF2 gene therapy using Mcp-1 promoter in retinal ganglion cell injury","volume":"5","author":"Fujita","year":"(2017)","journal-title":"Mol Ther Methods Clin Dev"},{"key":"R33-15-20230626","first-page":"73","article-title":"Neurodegeneration and neuroprotection in glaucoma","volume":"89","author":"Gauthier","year":"(2016)","journal-title":"Yale J Biol Med"},{"key":"R34-15-20230626","doi-asserted-by":"crossref","first-page":"25158414221134602","DOI":"10.1177\/25158414221134602","article-title":"RNA-based therapies in inherited retinal diseases","volume":"14","author":"Girach","year":"(2022)","journal-title":"Ther Adv Ophthalmol"},{"key":"R35-15-20230626","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/ncrna5030046","article-title":"The growth-arrest-specific (GAS)-5 long non-coding RNA:a fascinating lncRNA widely expressed in cancers","volume":"5","author":"Goustin","year":"(2019)","journal-title":"Non-coding RNA"},{"key":"R36-15-20230626","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1146\/annurev.cellbio.16.1.653","article-title":"The Myc\/Max\/Mad network and the transcriptional control of cell behavior","volume":"16","author":"Grandori","year":"(2000)","journal-title":"Annu Rev Cell Dev Biol"},{"key":"R37-15-20230626","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10792-021-02044-0","article-title":"Testing the eligibility of glaucoma patients for potential gene therapy among a clinic population","volume":"42","author":"Gruzei","year":"(2022)","journal-title":"Int Ophthalmol"},{"key":"R38-15-20230626","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1016\/j.cell.2021.06.031","article-title":"Preservation of vision after CaMKII-mediated protection of retinal ganglion cells","volume":"184","author":"Guo","year":"(2021)","journal-title":"Cell"},{"key":"R39-15-20230626","doi-asserted-by":"crossref","first-page":"e1230","DOI":"10.1002\/cl2.1230","article-title":"PRISMA2020:An R package and Shiny app for producing PRISMA |y2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis","volume":"18","author":"Haddaway","year":"(2022)","journal-title":"Campbell Syst Rev"},{"key":"R40-15-20230626","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1172\/JCI30178","article-title":"The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma","volume":"117","author":"Harada","year":"(2007)","journal-title":"J Clin Invest"},{"key":"R41-15-20230626","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/srep00530","article-title":"The Bcl-2 family member BIM has multiple glaucoma-relevant functions in DBA\/2J mice","volume":"2","author":"Harder","year":"(2012)","journal-title":"Sci Rep"},{"key":"R42-15-20230626","doi-asserted-by":"crossref","first-page":"E3839","DOI":"10.1073\/pnas.1608769114","article-title":"Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective","volume":"114","author":"Harder","year":"(2017)","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R43-15-20230626","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1113\/jphysiol.2008.154609","article-title":"Glutamatergic calcium dynamics and deregulation of rat retinal ganglion cells","volume":"586","author":"Hartwick","year":"(2008)","journal-title":"J Physiol"},{"key":"R44-15-20230626","doi-asserted-by":"crossref","first-page":"879957","DOI":"10.3389\/fcell.2022.879957","article-title":"From bench to bed:the current genome editing therapies for glaucoma","volume":"10","author":"He","year":"(2022)","journal-title":"Front Cell Dev Biol"},{"key":"R45-15-20230626","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/jop.2017.0041","article-title":"Targets of neuroprotection in glaucoma","volume":"34","author":"He","year":"(2018)","journal-title":"J Ocul Pharmacol Ther"},{"key":"R46-15-20230626","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/gt.2008.178","article-title":"Cellular tropism and transduction properties of seven adeno-associated viral vector serotypes in adult retina after intravitreal injection","volume":"16","author":"Hellstr\u00f6m","year":"(2009)","journal-title":"Gene Ther"},{"key":"R47-15-20230626","doi-asserted-by":"crossref","first-page":"e47869","DOI":"10.1371\/journal.pone.0047869","article-title":"Nicotinamide mononucleotide adenylyltransferase 2 (Nmnat2) regulates axon integrity in the mouse embryo","volume":"7","author":"Hicks","year":"(2012)","journal-title":"PLoS One"},{"key":"R48-15-20230626","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/jnc.12325","article-title":"Critical role of Nrf2 in oxidative stress-induced retinal ganglion cell death","volume":"127","author":"Himori","year":"(2013)","journal-title":"J Neurochem"},{"key":"R49-15-20230626","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12974-016-0499-5","article-title":"Virus-mediated EpoR76E gene therapy preserves vision in a glaucoma model by modulating neuroinflammation and decreasing oxidative stress","volume":"13","author":"Hines-Beard","year":"(2016)","journal-title":"J Neuroinflammation"},{"key":"R50-15-20230626","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41433-022-02169-1","article-title":"The application and progression of CRISPR\/Cas9 technology in ophthalmological diseases","volume":"37","author":"Hu","year":"(2023)","journal-title":"Eye (Lond"},{"key":"R51-15-20230626","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/acs.molpharmaceut.0c00992","article-title":"Enhanced delivery of siRNA to retinal ganglion cells by intravitreal lipid nanoparticles of positive charge","volume":"18","author":"Huang","year":"(2021)","journal-title":"Mol Pharm"},{"key":"R52-15-20230626","first-page":"816","article-title":"Tyrosine triple mutated AAV2-BDNF gene therapy in a rat model of transient IOP elevation","volume":"22","author":"Igarashi","year":"(2016)","journal-title":"Mol Vis"},{"key":"R53-15-20230626","first-page":"1641","article-title":"The prevalence of primary open-angle glaucoma in Japanese:the Tajimi Study","volume":"111","author":"Iwase","year":"(2004)","journal-title":"Ophthalmology"},{"key":"R54-15-20230626","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1073\/pnas.1706193114","article-title":"CRISPR-Cas9-based treatment of myocilin-associated glaucoma","volume":"114","author":"Jain","year":"(2017)","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R55-15-20230626","first-page":"799","article-title":"Adeno-associated virus mediated SOD gene therapy protects the retinal ganglion cells from chronic intraocular pressure elevation induced injury via attenuating oxidative stress and improving mitochondrial dysfunction in a rat model","volume":"8","author":"Jiang","year":"(2016)","journal-title":"Am J Transl Res"},{"key":"R56-15-20230626","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.exer.2010.05.016","article-title":"Neurotrophic factor delivery as a protective treatment for glaucoma","volume":"93","author":"Johnson","year":"(2011)","journal-title":"Exp Eye Res"},{"key":"R57-15-20230626","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s40291-020-00475-6","article-title":"Voretigene neparvovec:a review in RPE65 mutation-associated inherited retinal dystrophy","volume":"24","author":"Kang","year":"(2020)","journal-title":"Mol Diagn Ther"},{"key":"R58-15-20230626","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.4103\/1673-5374.272578","article-title":"Role of animal models in glaucoma research","volume":"15","author":"Kimura","year":"(2020)","journal-title":"Neural Regen Res"},{"key":"R59-15-20230626","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3390\/ijms17091584","article-title":"Neuroprotection, growth factors and BDNF-TrkB signalling in retinal degeneration","volume":"17","author":"Kimura","year":"(2016)","journal-title":"Int J Mol Sci"},{"key":"R60-15-20230626","doi-asserted-by":"crossref","first-page":"101013","DOI":"10.1016\/j.preteyeres.2021.101013","article-title":"Retinal pigment epithelium 65 kDa protein (RPE65):an update","volume":"88","author":"Kiser","year":"(2022)","journal-title":"Prog Retin Eye Res"},{"key":"R61-15-20230626","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.4049\/jimmunol.1601488","article-title":"Overexpression of soluble Fas ligand following adeno-associated virus gene therapy prevents retinal ganglion cell death in chronic and acute murine models of glaucoma","volume":"197","author":"Krishnan","year":"(2016)","journal-title":"J Immunol"},{"key":"R62-15-20230626","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3390\/jpm12111884","article-title":"Neuroprotection in glaucoma:basic aspects and clinical relevance","volume":"12","author":"Kuo","year":"(2022)","journal-title":"J Pers Med"},{"key":"R63-15-20230626","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/iovs.63.2.5","article-title":"Neuroprotective gene therapy by overexpression of the transcription factor MAX in rat models of glaucomatous neurodegeneration","volume":"63","author":"Lani-Louzada","year":"(2022)","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R64-15-20230626","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/bs.pbr.2015.05.005","article-title":"Retinal ganglion cell apoptotic pathway in glaucoma:Initiating and downstream mechanisms","volume":"220","author":"Levkovitch-Verbin","year":"(2015)","journal-title":"Prog Brain Res"},{"key":"R65-15-20230626","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1017\/S0952523805225130","article-title":"Inherited glaucoma in DBA\/2J mice:pertinent disease features for studying the neurodegeneration","volume":"22","author":"Libby","year":"(2005)","journal-title":"Vis Neurosci"},{"key":"R66-15-20230626","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.4161\/auto.36076","article-title":"Oxidative stress induces autophagy in response to multiple noxious stimuli in retinal ganglion cells","volume":"10","author":"Lin","year":"(2014)","journal-title":"Autophagy"},{"key":"R67-15-20230626","doi-asserted-by":"crossref","first-page":"107502","DOI":"10.1016\/j.biotechadv.2019.107502","article-title":"The approved gene therapy drugs worldwide: from 1998 to 2019","volume":"40","author":"Ma","year":"(2020)","journal-title":"Biotechnol Adv"},{"key":"R68-15-20230626","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/01926230701197107","article-title":"Review of the application of RNA interference technology in the pharmaceutical industry","volume":"35","author":"Martineau","year":"(2007)","journal-title":"Toxicol Pathol"},{"key":"R69-15-20230626","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/mt.2013.216","article-title":"In vitro and in vivo efficacy of SYL040012, a novel siRNA compound for treatment of glaucoma","volume":"22","author":"Mart\u00ednez","year":"(2014)","journal-title":"Mol Ther"},{"key":"R70-15-20230626","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1006\/mthe.2002.0608","article-title":"Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model","volume":"5","author":"McKinnon","year":"(2002)","journal-title":"Mol Ther"},{"key":"R71-15-20230626","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41419-018-0780-x","article-title":"Nogo-A inactivation improves visual plasticity and recovery after retinal injury","volume":"9","author":"Mdzomba","year":"(2018)","journal-title":"Cell Death Dis"},{"key":"R72-15-20230626","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/14712598.2018.1389886","article-title":"Gene therapy for inherited retinal and optic nerve degenerations","volume":"18","author":"Moore","year":"(2018)","journal-title":"Expert Opin Biol Ther"},{"key":"R73-15-20230626","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/gt.2013.64","article-title":"Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach","volume":"21","author":"Mowat","year":"(2014)","journal-title":"Gene Ther"},{"key":"R74-15-20230626","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/17469899.2017.1259566","article-title":"Role of BDNF\/TrkB pathway in the visual system:therapeutic implications for glaucoma","volume":"12","author":"Mysona","year":"(2017)","journal-title":"Expert Rev Ophthalmol"},{"key":"R75-15-20230626","doi-asserted-by":"crossref","first-page":"101883","DOI":"10.1016\/j.redox.2021.101883","article-title":"Retinal oxidative stress activates the NRF2\/ARE pathway:an early endogenous protective response to ocular hypertension","volume":"42","author":"Naguib","year":"(2021)","journal-title":"Redox Biol"},{"key":"R76-15-20230626","doi-asserted-by":"crossref","first-page":"118712","DOI":"10.1016\/j.lfs.2020.118712","article-title":"Small interfering RNAs (siRNAs) based gene silencing strategies for the treatment of glaucoma:recent advancements and future perspectives","volume":"264","author":"Naik","year":"(2021)","journal-title":"Life Sci"},{"key":"R77-15-20230626","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2156-15-42","article-title":"Determining immune components necessary for progression of pigment dispersing disease to glaucoma in DBA\/2J mice","volume":"15","author":"Nair","year":"(2014)","journal-title":"BMC Genet"},{"key":"R78-15-20230626","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1167\/tvst.11.11.8","article-title":"AAV2-mediated expression of HspB1 in RGCs prevents somal damage and axonal transport deficits in a mouse model of ocular hypertension","volume":"11","author":"Nam","year":"(2022)","journal-title":"Transl Vis Sci Technol"},{"key":"R79-15-20230626","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41434-019-0089-0","article-title":"Effects of a combinatorial treatment with gene and cell therapy on retinal ganglion cell survival and axonal outgrowth after optic nerve injury","volume":"27","author":"Nascimento-Dos-Santos","year":"(2020)","journal-title":"Gene Ther"},{"key":"R80-15-20230626","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ymthe.2022.11.018","article-title":"Vision protection and robust axon regeneration in glaucoma models by membrane-associated Trk receptors","volume":"31","author":"Nishijima","year":"(2023)","journal-title":"Mol Ther"},{"key":"R81-15-20230626","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1089\/hum.2017.069","article-title":"Design of a novel gene therapy construct to achieve sustained brain-derived neurotrophic factor signaling in neurons","volume":"29","author":"Osborne","year":"(2018a)","journal-title":"Hum Gene Ther"},{"key":"R82-15-20230626","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41419-018-1041-8","article-title":"Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor\/tropomyosin-related kinase receptor-B signaling","volume":"9","author":"Osborne","year":"(2018b)","journal-title":"Cell Death Dis"},{"key":"R83-15-20230626","doi-asserted-by":"crossref","first-page":"1131356","DOI":"10.3389\/fncel.2023.1131356","article-title":"Deficiency of the RNA-binding protein ELAVL1\/HuR leads to the failure of endogenous and exogenous neuroprotection of retinal ganglion cells","volume":"17","author":"Pacwa","year":"(2023)","journal-title":"Front Cell Neurosci"},{"key":"R84-15-20230626","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41598-022-27126-6","article-title":"Small molecule targeting long noncoding RNA GAS5 administered intranasally improves neuronal insulin signaling and decreases neuroinflammation in an aged mouse model","volume":"13","author":"Patel","year":"(2023)","journal-title":"Sci Rep"},{"key":"R85-15-20230626","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.3390\/ijms20215491","article-title":"The development of functional non-viral vectors for gene delivery","volume":"20","author":"Patil","year":"(2019)","journal-title":"Int J Mol Sci"},{"key":"R86-15-20230626","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1167\/iovs.08-3013","article-title":"Effect of CNTF on retinal ganglion cell survival in experimental glaucoma","volume":"50","author":"Pease","year":"(2009)","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R87-15-20230626","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jcp.10404","article-title":"Early nuclear exclusion of the transcription factor max is associated with retinal ganglion cell death independent of caspase activity","volume":"198","author":"Petrs-Silva","year":"(2004)","journal-title":"J Cell Physiol"},{"key":"R88-15-20230626","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/mt.2008.269","article-title":"High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors","volume":"17","author":"Petrs-Silva","year":"(2009)","journal-title":"Mol Ther"},{"key":"R89-15-20230626","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00441-013-1671-1","article-title":"Neuroprotection of medical IOP-lowering therapy","volume":"353","author":"Pfeiffer","year":"(2013)","journal-title":"Cell Tissue Res"},{"key":"R90-15-20230626","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3389\/fnins.2018.00834","article-title":"The role of endogenous neuroprotective mechanisms in the prevention of retinal ganglion cells degeneration","volume":"12","author":"Pietrucha-Dutczak","year":"(2018)","journal-title":"Front Neurosci"},{"key":"R91-15-20230626","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3390\/v13081526","article-title":"Designing lentiviral vectors for gene therapy of genetic diseases","volume":"13","author":"Poletti","year":"(2021)","journal-title":"Viruses"},{"key":"R93-15-20230626","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3390\/biom11040581","article-title":"Use of gene therapy in retinal ganglion cell neuroprotection:current concepts and future directions","volume":"11","author":"Rhee","year":"(2021)","journal-title":"Biomolecules"},{"key":"R94-15-20230626","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41434-019-0105-4","article-title":"Transduction optimization of AAV vectors for human gene therapy of glaucoma and their reversed cell entry characteristics","volume":"27","author":"Rodriguez-Estevez","year":"(2020)","journal-title":"Gene Ther"},{"key":"R95-15-20230626","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3390\/antiox10101538","article-title":"Oxidative stress in optic neuropathies","volume":"10","author":"Sanz-Morello","year":"(2021)","journal-title":"Antioxidants (Basel"},{"key":"R96-15-20230626","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1167\/iovs.07-0745","article-title":"Dependency of intraocular pressure elevation and glaucomatous changes in DBA\/2J and DBA\/2J-Rj mice","volume":"49","author":"Scholz","year":"(2008)","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R97-15-20230626","first-page":"225","article-title":"The diagnosis and treatment of glaucoma","volume":"117","author":"Schuster","year":"(2020)","journal-title":"Dtsch Arztebl Int"},{"key":"R98-15-20230626","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nrn2936","article-title":"Functions of Nogo proteins and their receptors in the nervous system","volume":"11","author":"Schwab","year":"(2010)","journal-title":"Nat Rev Neurosci"},{"key":"R99-15-20230626","first-page":"CD006539","article-title":"Neuroprotection for treatment of glaucoma in adults","volume":"1","author":"Sena","year":"(2017)","journal-title":"Cochrane Database Syst Rev"},{"key":"R100-15-20230626","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/s41419-018-1049-0","article-title":"Novel engineered, membrane-localized variants of vascular endothelial growth factor (VEGF) protect retinal ganglion cells:a proof-of-concept study","volume":"9","author":"Shen","year":"(2018)","journal-title":"Cell Death Dis"},{"key":"R101-15-20230626","first-page":"409","article-title":"Tyrosine triple mutated AAV2-BDNF gene therapy in an inner retinal injury model induced by intravitreal injection of N-methyl-D-aspartate (NMDA)","volume":"26","author":"Shiozawa","year":"(2020)","journal-title":"Mol Vis"},{"key":"R102-15-20230626","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1038\/srep05910","article-title":"A rat experimental model of glaucoma incorporating rapid-onset elevation of intraocular pressure","volume":"4","author":"Smedowski","year":"(2014)","journal-title":"Sci Rep"},{"key":"R103-15-20230626","doi-asserted-by":"crossref","first-page":"e0196565","DOI":"10.1371\/journal.pone.0196565","article-title":"Nogo receptor 1 is expressed by nearly all retinal ganglion cells","volume":"13","author":"Solomon","year":"(2018)","journal-title":"PLoS One"},{"key":"R104-15-20230626","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s13311-018-00694-0","article-title":"Gene therapy for neurodegenerative diseases","volume":"16","author":"Sudhakar","year":"(2019)","journal-title":"Neurotherapeutics"},{"key":"R105-15-20230626","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1128\/JVI.72.2.1438-1445.1998","article-title":"Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions","volume":"72","author":"Summerford","year":"(1998)","journal-title":"J Virol"},{"key":"R106-15-20230626","doi-asserted-by":"crossref","first-page":"104149","DOI":"10.1016\/j.isci.2022.104149","article-title":"Long-term and potent IOP-lowering effect of I\u03baB\u03b1-siRNA in a nonhuman primate model of chronic ocular hypertension","volume":"25","author":"Sun","year":"(2022)","journal-title":"iScience"},{"key":"R107-15-20230626","first-page":"1540","article-title":"Gamma-synuclein as a marker of retinal ganglion cells","volume":"14","author":"Surgucheva","year":"(2008)","journal-title":"Mol Vis"},{"key":"R108-15-20230626","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1350-9462(02)00010-1","article-title":"Myocilin and glaucoma:facts and ideas","volume":"21","author":"Tamm","year":"(2002)","journal-title":"Prog Retin Eye Res"},{"key":"R109-15-20230626","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.ymthe.2019.04.021","article-title":"Lentiviral vector-mediated expression of exoenzyme C3 transferase lowers intraocular pressure in monkeys","volume":"27","author":"Tan","year":"(2019)","journal-title":"Mol Ther"},{"key":"R110-15-20230626","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.omtm.2019.11.017","article-title":"C3 transferase-expressing scAAV2 transduces ocular anterior segment tissues and lowers intraocular pressure in mouse and monkey","volume":"17","author":"Tan","year":"(2020a)","journal-title":"Mol Ther Methods Clin Dev"},{"key":"R111-15-20230626","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.omtm.2020.04.014","article-title":"scAAV2-mediated C3 transferase gene therapy in a rat model with retinal ischemia\/reperfusion injuries","volume":"17","author":"Tan","year":"(2020b)","journal-title":"Mol Ther Methods Clin Dev"},{"key":"R112-15-20230626","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.ophtha.2018.04.040","article-title":"Rho kinase inhibitors as a novel treatment for glaucoma and ocular hypertension","volume":"125","author":"Tanna","year":"(2018)","journal-title":"Ophthalmology"},{"key":"R113-15-20230626","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1186\/s12967-022-03747-3","article-title":"Current strategies employed in the manipulation of gene expression for clinical purposes","volume":"20","author":"Tsai","year":"(2022)","journal-title":"J Transl Med"},{"key":"R114-15-20230626","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41434-021-00281-7","article-title":"XIAP gene therapy effects on retinal ganglion cell structure and function in a mouse model of glaucoma","volume":"29","author":"Visuvanathan","year":"(2022)","journal-title":"Gene Ther"},{"key":"R116-15-20230626","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"(2019)","journal-title":"Nat Rev Drug Discov"},{"key":"R117-15-20230626","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1523\/JNEUROSCI.0102-20.2020","article-title":"Mouse \u03b3-synuclein promoter-mediated gene expression and editing in mammalian retinal ganglion cells","volume":"40","author":"Wang","year":"(2020)","journal-title":"J Neurosci"},{"key":"R118-15-20230626","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1167\/iovs.14-15472","article-title":"Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models","volume":"56","author":"Wang","year":"(2015)","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R119-15-20230626","first-page":"e29533","article-title":"Ocular gene therapy:a literature review with focus on current clinical trials","volume":"14","author":"Wasnik","year":"(2022)","journal-title":"Cureus"},{"key":"R120-15-20230626","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma:a review","volume":"311","author":"Weinreb","year":"(2014)","journal-title":"JAMA"},{"key":"R121-15-20230626","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1089\/jop.2019.0146","article-title":"Matrix metalloproteinases and glaucoma treatment","volume":"36","author":"Weinreb","year":"(2020)","journal-title":"J Ocul Pharmacol Ther"},{"key":"R122-15-20230626","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1093\/hmg\/ddx184","article-title":"Genetics of glaucoma","volume":"26","author":"Wiggs","year":"(2017)","journal-title":"Hum Mol Genet"},{"key":"R123-15-20230626","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev-vision-022720-094953","article-title":"Axon regeneration in the mammalian optic nerve","volume":"6","author":"Williams","year":"(2020)","journal-title":"Annu Rev Vis Sci"},{"key":"R124-15-20230626","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/gt.2011.142","article-title":"Gene therapy for retinal ganglion cell neuroprotection in glaucoma","volume":"19","author":"Wilson","year":"(2012)","journal-title":"Gene Ther"},{"key":"R125-15-20230626","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.3390\/ijms21176262","article-title":"Neuroprotection of retinal ganglion cells with AAV2-BDNF pretreatment restoring normal TrkB receptor protein levels in glaucoma","volume":"21","author":"W\u00f3jcik-Gryciuk","year":"(2020)","journal-title":"Int J Mol Sci"},{"key":"R126-15-20230626","doi-asserted-by":"crossref","first-page":"10179","DOI":"10.3390\/ijms231710179","article-title":"Retinal ganglion cell survival and axon regeneration after optic nerve injury:role of inflammation and other factors","volume":"23","author":"Wong","year":"(2022)","journal-title":"Int J Mol Sci"},{"key":"R127-15-20230626","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ymthe.2019.12.012","article-title":"Gene therapy for glaucoma by ciliary body aquaporin 1 disruption using CRISPR-Cas9","volume":"28","author":"Wu","year":"(2020)","journal-title":"Mol Ther"},{"key":"R128-15-20230626","doi-asserted-by":"crossref","first-page":"983195","DOI":"10.3389\/fcell.2022.983195","article-title":"New strategies for neuro protection in glaucoma","volume":"10","author":"Xuejiao","year":"(2022)","journal-title":"Front Cell Dev Biol"},{"key":"R129-15-20230626","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1515\/revneuro-2013-0003","article-title":"Optic neuropathies:characteristic features and mechanisms of retinal ganglion cell loss","volume":"24","author":"You","year":"(2013)","journal-title":"Rev Neurosci"},{"key":"R131-15-20230626","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.exer.2006.09.022","article-title":"Dexamethasone inhibition of trabecular meshwork cell phagocytosis and its modulation by glucocorticoid receptor beta","volume":"84","author":"Zhang","year":"(2007)","journal-title":"Exp Eye Res"},{"key":"R132-15-20230626","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.tins.2017.01.001","article-title":"Advancing NMDA receptor physiology by integrating multiple approaches","volume":"40","author":"Zhou","year":"(2017)","journal-title":"Trends Neurosci"},{"key":"R133-15-20230626","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1089\/hum.2019.056","article-title":"Silencing of GAS5 alleviates glaucoma in rat models by reducing retinal ganglion cell apoptosis","volume":"30","author":"Zhou","year":"(2019)","journal-title":"Hum Gene Ther"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.375319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:10:08Z","timestamp":1787760608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.375319"}},"subtitle":["the dream that has not come true yet"],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":130,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/1673-5374.375319","relation":{},"ISSN":["1673-5374"],"issn-type":[{"value":"1673-5374","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]}}}